Global X
GNOM
IE00BM8R0N95
Genomics & Biotechnology UCITS ETF
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
35.27
Weighted Fwd P/E
-105.75
Avg P/FCF
50.84
Avg FCF Yield
-0.12%
Avg EV / EBITDA
77.95
Avg EV / Revenue
25.22
Avg Price-to-Book (P/B)
16.67
Avg Price-to-Sales (P/S)
31.43
Avg Dividend Yield
0.01%
P/E Compression (Trailing vs Fwd)
-399.8%
Avg Debt-to-Equity (D/E)
51.65%
<50% (64.16%) 50-150% (18.55%) >150% (10.54%) Unreported (6.76%)

Profitability Analysis

50 Holdings Count
Profitable 52.29%
Profitable 52.29%
24 Holdings Count (48%)
Unprofitable 47.71%
26 Holdings Count (52%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

Moderate Concentration
Top 5
30.5%
Top 10
50.2%
Top 25
85.1%
50% Threshold
Top 10
The top 10 positions account for 50.2% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

6 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (21.0%+)
High (54.6%+)
Top (75.7%+)

Country Breakdown

Max: 84.07%
US US US
84.07%
NL NL NL
5.23%
HK HK HK
3.76%
CH CH CH
2.80%
DE DE DE
2.74%
GB GB GB
1.24%

Sector Distribution

2 Sector
Healthcare
99.57%
Technology
0.27%

Industry Distribution

5 Industries
Biotechnology
57.60%
Diagnostics & Research
29.18%
Medical Devices
6.99%
Drug Manufacturers - General
5.80%
Scientific & Technical Instruments
0.27%

Market Cap Distribution

50 Holdings Count
Mega Cap (> 200B)
(2) 3.10%
Large Cap (10B - 200B)
(13) 41.27%
Mid Cap (2B - 10B)
(15) 41.69%
Small / Micro Cap (< 2B)
(20) 13.78%
ende